Publikationen Zentrum für blasenbildende Autoimmundermatosen

Borradori L, Van Beek N, Feliciani C, Tedbirt B, Antiga E, Bergman R, Böckle BC, Caproni M, Caux F, Chandran NS, Cianchini G, Daneshpazhooh M, De D, Didona D, Di Zenzo GM, Dmochowski M, Drenovska K, Ehrchen J, Goebeler M, Groves R, Günther C, Horvath B, Hertl M, Hofmann S, Ioannides D, Itzlinger-Monshi B, Jedličková J, Kowalewski C, Kridin K, Lim YL, Marinovic B, Marzano AV, Mascaro JM, Meijer JM, Murrell D, Patsatsi K, Pincelli C, Prost C, Rappersberger K, Sárdy M, Setterfield J, Shahid M, Sprecher E, Tasanen K, Uzun S, Vassileva S, Vestergaard K, Vorobyev A, Vujic I, Wang G, Wozniak K, Yayli S, Zambruno G, Zillikens D, Schmidt E, Joly P (2022)
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology 2022 Oct; 36(10): 1689-1704
Zur Publikation

Dikmen HO, Yilmaz K, Benoit S, Bernard P, Drenovska K, Gerdes S, Gläser R, Günther C, Homey B, Horváth ON, Huilaja L, Joly P, Kiritsi D, Meller S, Patsatsi A, Sárdy M, Schauer F, Shahid M, Sticherling M, Tasanen K, Vassileva S, Worm M, Zillikens D, Sadik CD, van Beek N, König IR, Schmidt E (2022)
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.
Journal of the European Academy of Dermatology & Venereology 2022 Nov; 36(11): 2181-2189
Zur Publikation

Goebeler M, Bata-Csörgő Z, De Simone C, Didona B, Remenyik E, Reznichenko N, Stoevesandt J, Ward ES, Parys W, de Haard H, Dupuy P, Verheesen P, Schmidt E, Joly P and the ARGX-113-1701 Investigator Study Group (2022)
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase 2 multicentre, open-label feasibility trial.
British Journal of Dermatology 2022 Mar; 186(3): 429-439. 
Zur Publikation

Hoch VB, Kohler AF, Augusto DG, Lobo-Alves SC, Malheiros D, Cipolla GA, Boldt ABW, Braun-Prado K, Wittig M, Franke A, Pföhler C, Worm M, van Beek N, Goebeler M, Sárdy M, Ibrahim S, Busch H, Schmidt E, Hundt JE, Araujo-Souza PS, Petzl-Erler ML (2022)
Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus.
Viruses 2022 Apr 23; 14(5): 879
Zur Publikation

Hofmann SC, Günther C, Böckle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, Gläser R, Hadaschik E, Hampl M, Haßkamp P, Jackowski J, Kiritsi D, Nast A, Pleyer U, Reichel C, Roth M, Schumann M, Sticherling M, Worm M, Zillikens D, Goebeler M, Schmidt E (2022)
S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid.
Journal of the German Society of Dermatology 2022 Nov; 20(11): 1530-1550.
Zur Publikation

Yilmaz K, Goletz S, Pas HH, van den Bos RR, Blauvelt A, White WL, Bouaziz JD, Zuelgaray E, Daneshpazhooh M, Yancey KB, Goebeler M, Schmidt E (2022)
Clinical and serological characterization of orf-induced immunobullous disease.
JAMA Dermatology 2022 Jun 1; 158(6): 670-674.
Zur Publikation

Maho-Vaillant M, Sips M, Golinski L, Vidarsson G, Goebeler M, Stoevesandt J, Bata‐Csörgő Z, Balbino B, Verheesen P, Joly P, Hertl M, Calbo S (2022)
FcRn antagonism leads to a decrease of desmoglein-specific B cells: secondary analysis of a phase 2 study of Efgartigimod in Pemphigus vulgaris and Pemphigus foliaceus.
Frontiers in Immunology 2022 May 18; 13: 863095
Zur Publikation

Martin E, Mauer I, Malzahn U, Heuschmann PU, Goebeler M, Benoit S (2022)
Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study.
Journal of the German Society of Dermatology 2022 Jun; 20(6): 798-805 
Zur Publikation

Mohme S, Stoevesandt J, Goebeler M, Hamm H (2022)
A blistering child-A girl with mysterious blisters.
European Journal of Dermatology 2022 Apr 1; 32(2): 294-296.
Zur Publikation

Mohme S, Goebeler M, Hamm H (2021)
A child with blistering skin lesions: a crown of jewels.
European Journal of Dermatology 2021 Apr 1; 31(2): 285-286
Zur Publikation

Salviano-Silva  A, Becker M, Augusto DG, Busch H, Adelman Cipolla G, Farias TD, Bumiller-Bini V, Calonga-Solís V, Munz M, Franke A, Wittig M, Camargo CM, Goebeler M, Hundt JE, Günther C, Gläser R, Hadaschik E, Pföhler C, Sárdy M, Van Beek N, Worm M, Zillikens D, Boldt ABW, Schmidt E, Petzl-Erler ML, Ibrahim S, Malheiros D (2021)
Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
Journal of Autoimmunity 2021 Sep; 123:102705
Zur Publikation

Salviano-Silva A, Farias TDJ, Bumiller-Bini V, Castro MS, Lobo-Alves SC, Busch H, Pföhler C, Worm M, Goebeler M, van Beek N, Franke A, Wittig M, Zillikens D, de Almeida RC, Hundt JE, Boldt ABW, Ibrahim S, Augusto DG, Petzl-Erler ML, Schmidt E, Malheiros D (2021)
Genetic variability of immune-related lncRNAs: polymorphisms in LINC-PINT and LY86-AS1 are associated with pemphigus foliaceus susceptibility.
Experimental Dermatology 2021 Jun; 30(6): 831-840
Zur Publikation

Schmitt T, Egu DT, Walter E, Sigmund AM, Eichkorn R, Yazdi A, Schmidt E, Sárdy M, Eming R, Goebeler M, Waschke J (2021)
Ca2+ signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.
British Journal of Dermatology 2021 Sep; 185(3): 595-604
Zur Publikation

Schwarm C, Gola D, Holtsche MM, Dieterich A, Bhandari A, Freitag M, Nürnberg P, Toliat M, Lieb W, Wittig M, Franke A, Worm M, Sticherling M, Ehrchen J, Günther C, Gläser R, Peitsch WK, Sárdy M, Eming R, Hertl M, Benoit S, Goebeler M, Pföhler C, Kunz M, Kreuter A, van Beek N, Erdmann J, Busch H, Zillikens D, Sadik CD, Hirose M, König IR, Schmidt E, Ibrahim SM (2021)
Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans. German AIBD Study Group.
Orphanet Journal of Rare Diseases 2021 May 19; 16(1): 228
Zur Publikation

Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M (2020)
COVID-19 and implications for dermatological and allergological diseases.
Journal of the German Society of Dermatology (JDDG) 2020 Aug; 18(8): 815-824
Zur Publikation 

Hosp C, Goebeler M, Benoit S, Stoevesandt J (2020)
Rituximab-induzierte, verzögert auftretende Neutropenie bei blasenbildenden Autoimmunerkrankungen: harmlos oder unterschätzte Gefahr?
Journal of the German Society of Dermatology (JDDG) 2020 Oct 28; 18(10): 1162-1164
No abstract available
Zur Publikation

Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, Bergman R, Bernard P, Borradori L, Caproni M, Caux F, Cianchini G, Daneshpazhooh M, De D, Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R, Guenther C, Hofmann S, Ioannides D, Kowalewski C, Ludwig R, Lim YL, Marinovic B, Marzano AV, Mascaró JM Jr, Mimouni D, Murrell DF, Pincelli C, Squarcioni CP, Sárdy M, Setterfield J, Sprecher E, Vassileva S, Wozniak K, Yayli S, Zambruno G, Zillikens D, Hertl M, Schmidt E (2020)
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).
Journal of the European Academy of Dermatology & Venereology 2020 Sep 24; 34(9): 1900-1913
Zur Publikation

Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J (2020)
Impfen bei Immunsuppression: ein Leitfaden für die dermatologische Praxis.
Journal of the German Society of Dermatology (JDDG) 2020 Jul 26; 18(7): 699-725
Zur Publikation

Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Nast A, Orzechowski HD, Pfeiffer C, Schuster V, Sitaru C, Zidane M, Zillikens D, Worm M (2020)
S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update.
Journal of the German Society of Dermatology (JDDG) 2020 May 15; 18(5): 516-527
Zur Publikation

Stoevesandt J, Heitmann J, Goebeler M, Benoit S (2020)
Neutropenia resulting from high-dose intravenous immunoglobulin in dermatological patients.
Journal of the German Society of Dermatology (JDDG) 2020 Dec; 18(12): 1394-1403
Zur Publikation

Grän F, Goebeler M, Gesierich A. Eur J Dermatol (2019)
Bullous pemphigoid developing upon immune checkpoint inhibition with nivolumab.
European Journal of Dermatology 2019 Aug 1; 29(4): 448-449
No abstract available
Zur Publikation

Russlies J, Fähnrich A, Witte M, Yin J, Benoit S, Gläser R, Günter C, Eming R, Erdmann J, Gola D, Gupta Y, Holtsche MM, Kern JS, König IR, Kiritsi D, Lieb W, Sadik CD, Sárdy M, Schauer F, van Beek N, Weidinger A, Worm M, Zillikens D, Schmidt E, Busch H, Ibrahim SM, Hirose M (2019)
Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
Frontiers in Immunology 2019 Nov 22; 10: 2200
Zur Publikation